Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study

Aung Naing; John D Powderly; John J Nemunaitis; Jason J Luke; Aaron S Mansfield; Wells A Messersmith; Solmaz Sahebjam; Patricia M LoRusso; Ignacio Garrido-Laguna; Lance Leopold; Ryan Geschwindt; Kai Ding; Michael Smith; Jordan D Berlin

doi:10.1136/jitc-2021-004223

Article metrics

This article has a correction. Please see:

Correction: Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study - October 01, 2022

PDF

PDF +
Supplementary
Material

Clinical/translational cancer immunotherapy

Original research

Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study

Online download statistics by month:

Online download statistics by month: March 2022 to April 2023

	Abstract	Full	Pdf
Mar 2022	414	422	191
Apr 2022	307	319	130
May 2022	179	182	82
Jun 2022	175	177	56
Jul 2022	231	232	34
Aug 2022	184	186	59
Sep 2022	160	164	53
Oct 2022	200	205	53
Nov 2022	130	131	40
Dec 2022	131	131	36
Jan 2023	122	122	29
Feb 2023	113	113	27
Mar 2023	116	116	23
Apr 2023	65	66	43
Total	2527	2566	856

Log in using your username and password

Main menu

Log in using your username and password

You are here

This article has a correction. Please see:

Online download statistics by month:

Online download statistics by month: March 2022 to April 2023

Read the full text or download the PDF:

Log in using your username and password